Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.
Hartley HE, Fong FC, Gabriel AS, Stevenson LK, Beckett E, Allinson LM, Goodman A, Potts A, Whittle E, Barford R, Lamparelli A, Herd F, Mazzocco K, Pezzolo A, Morini M, Ardito M, Eva A, Ognibene M, Fischer M, Ackermann S, Rosswog C, Hero B, Smith GR, Unsworth AA, McCorkindale M, George SL, Tall J, Molenaar JJ, Matser Y, Langenberg K, Tytgat G, Noguera R, Berbegall AP, de Mora JF, Combaret V, Pierron G, Mühlethaler-Mottet A, Schoumans J, Tchinda J, Banzola I, Jeison M, Hameiri-Grossman M, Beiske KH, Auger N, Van Roy N, Basta NO, McNally RJQ, Taschner-Mandl S, Papadakis V, Di Cataldo A, Wheeler K, Bermúdez JD, Beck-Popovic M, Segura V, Canete A, Schleiermacher G, Tweddle DA.
Hartley HE, et al. Among authors: potts a.
JCO Precis Oncol. 2026 Jul;10(7):e2600045. doi: 10.1200/PO-26-00045. Epub 2026 Jul 1.
JCO Precis Oncol. 2026.
PMID: 42385103
Free PMC article.